Pharmafile Logo
Pharmafocus logo
Advanced Search

diabetes

Showing 15 posts of 391 posts found.

oral_insulin

Moving forward in diabetes

October 6, 2015
Research and Development Novo Nordiak, diabetes

As many as 387 million people worldwide are living with diabetes, and it is predicted that by 2035 more than …

Feature
diabetes_uk_logo

Novo Nordisk and Diabetes UK extend ‘Clinical Champions’ initiative

October 6, 2015
Medical Communications Novo Nordisk, diabetes

Diabetes UK and Novo Nordisk have announced the appointment of 20 Diabetes UK ‘Clinical Champions’, who will be supported and …

News
Novo Nordisk building

FDA approves Novo Nordisk’s diabetes drugs

September 28, 2015
Sales and Marketing FDA, Novo Nordisk, Ryzodeg, Tresiba, diabetes, insulin

The FDA has approved two Novo Nordisk drugs, Tresiba and Ryzodeg, for the treatment of type 2 diabetes in adults.The …

News
nn_flag

Novo Nordisk to build manufacturing plant for FlexPen in Iran

September 22, 2015
Manufacturing and Production Iran, Novo Nordisk, diabetes

Novo Nordisk has announced that Novo Nordisk Iran and the Food and Drug Administration of the Islamic Republic of Iran …

News
diabetes_injection

Sanofi’s LixiLan meets target in Phase III diabetes trial

September 16, 2015
Research and Development Lantus, LixiLan, Lixisenatide, Lxyumia, Sanofi, diabetes, insulin glargine, metformin, type 2 diabetes

Sanofi’s Phase III clinical trial of its Lixilan treatment has achieved its primary endpoint in patients with type 2 diabetes, …

News
fda_building

FDA strengthens safety warning for J&J’s diabetes drug Invokana

September 14, 2015
Sales and Marketing FDA, Food and Drugs Administration, Invokamet, J&J, JJ, Johnson & Johnson, diabetes, invokana, safety warning, type 2 diabetes

Johnson & Johnson has suffered a blow after the FDA strengthened its safety warning for the company’s type 2 diabetes …

News
google logo

Sanofi joins Google in diabetes tech push

September 1, 2015
Medical Communications Andy Conrad, Google life sciences, Sanofi, Type 1 diabetes, diabetes, google, type 2 diabetes

Google is continuing its work in diabetes, by teaming up with pharma giants Sanofi to create new digital technologies and …

News
diabetes_injection

NICE targets tight blood sugar control in new diabetes guidelines

August 27, 2015
NICE, NICE guidelines, Public Health England, Type 1 diabetes, diabetes

NICE has urged healthcare professionals to target tighter blood sugar control, in a suite of recommendation in updated guidelines on …

News
novonordiskhq

Novo Nordisk abandons Victoza submission after mixed T1D results

August 26, 2015
Research and Development Novo Nordisk, Victoza, diabetes, insulin

Novo Nordisk has been forced to scrap plans to expand its licence for Victoza to include adults with type 1 …

News
Abasaglar

Lilly and Boehringer launch biosimilar insulin in the UK

August 26, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Boehringer, Boehringer Ingelheim, Eli Lilly, Lantus, abasaglar, basal insulin, biosimilar, biosimilars, diabetes, insuling glargine, lilly

Lilly and Boehringer Ingelheim have launched their biosimilar insulin, called abasaglar, for the UK market. Abasaglar will now challenge the …

News
Google sign

Google to expand diabetes monitoring technology

August 14, 2015
Medical Communications blood sugar, diabetes, glucose, google, smart technology, wearable tech

Google is teaming up with the diabetes device maker DexCom to build a small and affordable sensor that could help …

News

Cost of diabetes treatment in England rises

August 12, 2015
Manufacturing and Production, Sales and Marketing HSCIC, NHS, diabetes, health and social care information centre, prescribing

As diabetes patients increase in numbers the cost of treating the disease in England has increased to more than £800 …

News
Toujeo pen

Sanofi launches new insulin Toujeo in the UK

August 4, 2015
Manufacturing and Production, Sales and Marketing Lantus, Sanofi, biosimilars, diabetes, hypoglycaemia, insulin, toujeo

Sanofi’s new insulin Toujeo is now available for clinicians to prescribe in the UK. The French firm is looking to …

News

Novo Nordisk pushes forward with new diabetes drug trial

July 13, 2015
Research and Development GLP-1 agonist, Novo Nordisk, diabetes, phase III, semaglutide, type 2 diabetes

Novo Nordisk is taking the first steps towards adding another type 2 diabetes drug to its portfolio, after announcing positive …

News
Sanofi Paris HQ

Sanofi’s Toujeo approved in Japan

July 3, 2015
Manufacturing and Production, Sales and Marketing Japan, Lantus Lantus XR, Sanofi, diabetes, toujeo, type diabetes

The Ministry of Health, Labor and Welfare in Japan has given Sanofi a marketing authorisation for the diabetes drug the …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026